AbbVie Tshuag Skids Ntawm Mixed Earnings Report, Narrowed 2022 Cov Nyiaj Tau Los Saib

AbbVie Tshuag skidded Friday tom qab "ib ntus kev lag luam headwinds" hamstrung nws cov tshuaj zoo nkauj, suav nrog lub ntsej muag-filler Botox, thaum lub quarter thib peb.




X



Zuag qhia tag nrho, AbbVie's (ABBV) Kev kho mob zoo nkauj faib tau tsim $ 1.3 nphom hauv kev muag khoom. Nyob rau hauv nruj, raws li qhia hauv paus, kev muag khoom nce 4%. Qhov loj dua US ntu pom kev muag khoom poob ntau dua 7%. Tawm qhov ntawd, cov nyiaj tau los thoob ntiaj teb tau nce yuav luag 26%.

Thawj Tswj Hwm Richard Gonzalez tau sau tseg cov tshuaj tiv thaiv kab mob Skyrizi thiab Rinvoq tau pab txo qis kev zoo nkauj tsis zoo. Lub duo yuav tseem ceeb rau yav tom ntej thaum AbbVie tus kws kho mob loj tshaj plaws, kev kho tshuaj tiv thaiv kab mob hu ua Humira, poob kev tiv thaiv patent.

"Peb tseem pom lub zog muaj zog los ntawm peb cov cuab yeej tiv thaiv kab mob tseem ceeb, Skyrizi thiab Rinvoq, thiab qhov kev ua tau zoo no - ua ke nrog lub zog los ntawm lwm tus tsav tsheb loj hlob hauv peb cov ntaub ntawv sib txawv - tau txo qhov cuam tshuam ntawm kev lag luam ib ntus ntawm peb cov khoom zoo nkauj kom xa mus rau lwm lub quarter. cov txiaj ntsig muaj zog, ”nws hais hauv tsab ntawv ceeb toom.

Tab sis thaum sawv ntxov trading rau hnub no lub khw lag luam, AbbVie Tshuag poob 3.2%, ua lag luam ze 148.60.

AbbVie Tshuag: Ib Lub quarter thib peb sib xyaw

Lub quarter thib peb yog, los ntawm thiab loj, ib lub hnab sib xyaw rau AbbVie. Kho cov nyiaj khwv tau los yeej pom ntawm $ 3.66 ib feem, tab sis tag nrho kev muag khoom tuaj txog ntawm $ 14.81 nphom. Kev muag khoom tau nce mus txog 3% siab dua thiab cov nyiaj tau los tau nce ntau dua 29%.

Tab sis cov nyiaj tau los ntawm Humira plam qhov kev cia siab ntawm $ 5.56 billion. Txawm hais tias kev muag khoom tau nce 2.5%, lawv tuaj qis dua qhov kev cia siab rau $ 5.59 billion, Piper Sandler tus kws tshuaj ntsuam Christopher Raymond tau hais hauv tsab ntawv. Lub caij no, Skyrizi tuav cov kwv yees yuav luag $ 1.4 nphom, tab sis $ 695 lab hauv Rinvoq muag tsis tau.

Hauv kev faib ua kom zoo nkauj, Botox muag tau nce ze li ntawm 17% rau $ 637 lab thaum Juvederm cov nyiaj tau los poob ze li 1% rau $ 352 lab. Kev muag tshuaj Botox plam $ 641 lab kev kwv yees, tab sis Juvederm tau nyob hauv kab, Raymond tau hais.

Ob leeg tshuaj mob qog noj ntshav, Imbruvica thiab Venclexta, lagged ntawm $ 1.14 billion thiab $ 515 lab raws li. Kev muag khoom ntawm Imbruvica tau poob ntau dua 17%, txawm tias Venclexta eked tawm ib tus lej nce. Lub caij no, lub neuroscience franchise nco "tsis zoo," Raymond hais. Nws tau sau tseg tias tsis nco qab los ntawm Parkinson cov tshuaj Duodopa thiab kev kho mob migraine Ubrelvy. Kev muag tshuaj kho Botox sib npaug ntawm kev kwv yees ntawm $ 699 lab.

Rau lub xyoo, AbbVie txo nws cov nyiaj khwv tau los mus rau $ 13.84- $ 13.88 ib feem, tab sis khaws tib qhov nruab nrab. Lub tuam txhab tsis muaj kev qhia txog kev muag khoom. AbbVie cov kws tshuaj ntsuam xyuas cov khoom lag luam tau kwv yees kho cov nyiaj tau los ntawm $ 13.85 ib feem thiab $ 58.92 nphom hauv kev muag khoom.

Ua raws li Allison Gatlin ntawm Twitter ntawm @IBD_AGatlin.

KOJ UA LI CAS:

Merck surges nyob rau hauv yuav Zone raws li ob yam khoom tseem ceeb tsav nws Bullish Report

Yog vim li cas Pandemic Darlings Teladoc, Align Diverged Ntawm Lawv Cov Lus Qhia Peb Lub Peb Hlis

Cov Kev Xaiv Ua Lag Luam: Yuav Pib Siv Cov Kev Xaiv, Yuav Ua Li Cas Tswj Cov Kev Nyab Xeeb

Ua Raws Li Qhov Khw Ua Ntej Thiab Tom Qab-Qhov Haujlwm Qhib Nrog IBD Cov Kws Tshaj Lij

Cov Khoom Cuam Tshuam Yuav Yooj Yim Thiab Saib Xyuas: IPOs Sab saum toj, Lub Kaus Loj Loj Thiab Cov Me Me, Cov Lus Qhia Loj Hlob

Tau qhov twg los: https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q3-2022/?src=A00220&yptr=yahoo